invent Diagnostica

invent Diagnostica

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

in.vent Diagnostica is a long-established, private German company operating as a critical supplier and service provider in the global IVD ecosystem. Its core business revolves around ethically procuring and processing human biological samples (serum, plasma, tissues) into standardized products like controls, pools, and panels for diagnostic test development and validation. The company is investing in process innovation and expanding its product portfolio, including into areas like gastrointestinal disease controls, while serving a global clientele through digital platforms and trade fairs.

AllergyGastrointestinal DiseasesDiabetesGeneral Diagnostics

Technology Platform

A specialized biospecimen processing and characterization platform focused on the ethical sourcing, clinical definition, processing, stabilization, and quality control of human biological samples (serum, plasma, blood, tissues) for use in IVD development, validation, and quality assurance.

Opportunities

Growth is driven by the expanding global IVD market, particularly the need for validated samples under stricter regulations (IVDR).
Specific opportunities include expanding its portfolio into high-growth areas like gastrointestinal disease controls and capitalizing on the growing allergy diagnostics segment through its specialized allergen panels.

Risk Factors

Risks include dependence on the ethical and compliant sourcing of human biological samples, vulnerability to regulatory changes in the IVD industry (e.g., IVDR), and competition from larger, global life science reagents companies and other biospecimen suppliers.

Competitive Landscape

in.vent competes in the niche market for characterized human biological samples and IVD development services. Competitors range from large, diversified life science suppliers (e.g., Merck, Thermo Fisher Scientific) to other specialized biospecimen providers and control material manufacturers. Its differentiation lies in its focus on ethical sourcing, clinical characterization, and custom service offerings for the IVD industry.